Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3021% above fair value
$19.80−0.09 (-0.45%)
Close on Nov 16, 2026Market cap $1.00BP/E –Yield –
Cryoport cash
Cash and short-term investments held at the end of each period.
Cryoport's cash was $396.69M at Jun 30, 2026. For fiscal 2025 it was $411.21M, up 64.1% from the year before. Over ten years it grew 101.7% a year on average. The highest annual figure on record is $628.80M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $411.21M | +64.1% |
| FY2024 | Dec 31, 2024 | $250.60M | -45.1% |
| FY2023 | Dec 31, 2023 | $456.76M | -12.7% |
| FY2022 | Dec 31, 2022 | $523.32M | -16.8% |
| FY2021 | Dec 31, 2021 | $628.80M | +573.8% |
| FY2020 | Dec 31, 2020 | $93.32M | -1.0% |
| FY2019 | Dec 31, 2019 | $94.30M | +99.5% |
| FY2018 | Dec 31, 2018 | $47.26M | +1592.3% |
| FY2016 | Mar 31, 2016 | $2.79M | +98.7% |
| FY2015 | Mar 31, 2015 | $1.41M | +280.2% |
| FY2014 | Mar 31, 2014 | $369.58K | -34.4% |
| FY2013 | Mar 31, 2013 | $563.10K | -87.8% |
| FY2012 | Mar 31, 2012 | $4.62M | -50.2% |
| FY2011 | Mar 31, 2011 | $9.28M | +155.6% |
| FY2010 | Mar 31, 2010 | $3.63M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $396.69M | -6.9% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $403.63M | +65.4% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $411.21M | +64.1% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $421.31M | +54.5% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $425.98M | -0.3% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $244.03M | -45.6% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $250.60M | -45.1% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $272.67M | -41.5% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $427.14M | -15.4% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $448.54M | -14.2% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $456.76M | -12.7% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $465.86M | -12.0% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $504.67M | -8.3% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $522.61M | -12.8% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $523.32M | -16.8% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $529.53M | +51.5% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $550.62M | +57.6% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $599.51M | +69.7% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $628.80M | +573.8% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $349.48M | +72.2% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $349.41M | +67.8% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $353.22M | +262.5% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $93.32M | -1.0% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $202.94M | +117.0% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $208.22M | +119.8% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $97.43M | +106.1% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $94.30M | +99.5% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $93.50M | +294.0% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $94.75M | +373.5% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $47.27M | +148.9% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $47.26M | +1592.3% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $23.73M | +352.3% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $20.01M | +183.5% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $18.99M | +696.1% |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $2.79M | +98.7% |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | $5.25M | +578.0% |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | $7.06M | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | $2.39M | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | $1.41M | – |
| Q3 FY2015CQ4 2014 | Dec 31, 2014 | $773.92K | – |
See a number that looks wrong?